EGCG is shown to increase α-secretase activity and hydrolysis of the TNF-α-converting enzyme to promote the cleavage of the α-c terminal fragment of APP in a model of Alzheimer’s disease [47,48]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.